Literature DB >> 8271022

Hematoma enlargement in spontaneous intracerebral hemorrhage.

Y Fujii1, R Tanaka, S Takeuchi, T Koike, T Minakawa, O Sasaki.   

Abstract

In order to evaluate the incidence and risk factors of hematoma enlargement in spontaneous intracerebral hemorrhage (ICH), 419 cases of ICH were reviewed. The first computerized tomography (CT) scan was performed within 24 hours of onset and the second within 24 hours of admission; a blood sample was taken for laboratory examination within 1 hour of admission. In 60 patients (14.3%) the second CT scan showed an enlarged hematoma. The incidence of enlargement significantly decreased with time (p < 0.05) and significantly increased with the severity of liver dysfunction and the volume of the hematoma on the first CT scan. Patients with an irregularly shaped hematoma had a higher risk of hematoma growth than those with a round hematoma. In addition, patients with hematoma enlargement were more likely to have coagulation abnormalities (low platelet counts and low levels of fibrinogen, alpha 2-antiplasmin activity and platelet aggregation). Moreover, hematoma growth was associated with a poor clinical outcome. It is concluded that patients admitted to a hospital within 6 hours of onset of ICH, especially those admitted within 2 hours, and patients with liver dysfunction or irregularly shaped large hematomas should be closely observed for at least 6 hours after onset in preparation for emergency surgery, since the risk of hematoma growth in these circumstances is high.

Entities:  

Mesh:

Year:  1994        PMID: 8271022     DOI: 10.3171/jns.1994.80.1.0051

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  68 in total

1.  Subclinical change of liver function could also provide a clue on prognosis for patients with spontaneous intracerebral hemorrhage.

Authors:  Ge Tan; Zilong Hao; Chunyan Lei; Yanchao Chen; Ruozhen Yuan; Mangmang Xu; Ming Liu
Journal:  Neurol Sci       Date:  2016-07-08       Impact factor: 3.307

2.  Recombinant activated factor VII for acute intracerebral hemorrhage: US phase IIA trial.

Authors:  Stephan A Mayer; Nikolai C Brun; Joseph Broderick; Stephen M Davis; Michael N Diringer; Brett E Skolnick; Thorsten Steiner
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

3.  [Recommendations of the European Stroke Initiative for the diagnosis and treatment of spontaneous intracerebral haemorrhage].

Authors:  S Külkens; P Ringleb; J Diedler; W Hacke; T Steiner
Journal:  Nervenarzt       Date:  2006-08       Impact factor: 1.214

4.  Role of 'Spot Sign' on CT Angiography to Predict Hematoma Expansion in Spontaneous Intracerebral Hemorrhage.

Authors:  Soo Yong Park; Min Ho Kong; Jung Hee Kim; Dong Soo Kang; Kwan Young Song; Seung Kon Huh
Journal:  J Korean Neurosurg Soc       Date:  2010-11-30

Review 5.  The complement cascade as a therapeutic target in intracerebral hemorrhage.

Authors:  Andrew F Ducruet; Brad E Zacharia; Zachary L Hickman; Bartosz T Grobelny; Mason L Yeh; Sergey A Sosunov; E Sander Connolly
Journal:  Exp Neurol       Date:  2009-07-24       Impact factor: 5.330

Review 6.  Intracerebral haemorrhage.

Authors:  J M MacKenzie
Journal:  J Clin Pathol       Date:  1996-05       Impact factor: 3.411

7.  Intracerebral hemorrhage: clinical overview and pathophysiologic concepts.

Authors:  Fred Rincon; Stephan A Mayer
Journal:  Transl Stroke Res       Date:  2012-04-21       Impact factor: 6.829

Review 8.  [Acute stroke therapy. Current developments].

Authors:  T Steiner; E Jüttler; P Ringleb
Journal:  Nervenarzt       Date:  2007-10       Impact factor: 1.214

Review 9.  Stem cell therapy in intracerebral hemorrhage rat model.

Authors:  Marcos F Cordeiro; Ana P Horn
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

Review 10.  Clinical review: Critical care management of spontaneous intracerebral hemorrhage.

Authors:  Fred Rincon; Stephan A Mayer
Journal:  Crit Care       Date:  2008-12-10       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.